# Early Infant HIV Treatment in Botswana

> **NCT02369406** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Harvard School of Public Health (HSPH)** · enrollment: 67 (actual)

## Conditions studied

- HIV
- Pediatric AIDS

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** Kaletra
- **DRUG:** Lamivudine
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT02369406
- **Lead sponsor:** Harvard School of Public Health (HSPH)
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-05-04
- **Primary completion:** 2020-11-06
- **Final completion:** 2029-06-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369406, "Early Infant HIV Treatment in Botswana". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02369406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*